Head-to-Head

Abbott Laboratories vs. Entrada Therapeutics, Inc. Common Stock

ABT

Abbott Laboratories

$104.06 -0.79%

VS TRDA

Entrada Therapeutics, Inc. Common Stock

$5.09 +5.71%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTTRDA
Market Cap $181.50 billion $187.67 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTTRDA
Dividend Yield 2.42% —

ABT and TRDA split the dividend factors evenly.

Risk & Sentiment

ABTTRDA
Short Interest 0.57% 0.81%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, TRDA overview, TRDA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.